Gastrodin reduces tau hyperphosphorylation in 3xTg‐AD mice, reverses decreased brain matrix viscoelasticity, and remodels ECM components by targeting the Alzheimer's risk gene FERMT2, primarily in astrocytes. This evidence concerns the gene MAPT and Alzheimer disease.